Related Experiment Videos
Farnesylated proteins and cell cycle progression.
F Tamanoi1, J Kato-Stankiewicz, C Jiang
1Department of Microbiology, Immunology and Molecular Genetics, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California 90095-1489, USA. fuyut@microbio.ucla.edu
Journal of Cellular Biochemistry. Supplement
|February 14, 2002
Summary
Farnesylation, a protein modification, is vital for cell signaling and membrane association. Farnesyltransferase inhibitors (FTIs) impact cancer cell cycle progression, affecting key proteins like Rheb and CENP-E,F.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Post-translational modification by farnesylation is crucial for signal transduction proteins, aiding membrane association and protein interactions.
- Understanding the biological roles of farnesylation is an active area of research.
Purpose of the Study:
- To investigate the effects of farnesyltransferase inhibitors (FTIs) on cancer cell cycle progression.
- To identify and characterize novel farnesylated proteins and their functions.
Main Methods:
- Treatment of various human cancer cells with FTIs.
- Characterization of novel farnesylated proteins, including Rheb and CENP-E,F.
Main Results:
- FTIs alter cell cycle progression in cancer cells, causing G0/G1 enrichment or G2/M accumulation depending on the cell line.
- Novel farnesylated proteins Rheb (involved in G1 phase) and CENP-E,F (mitotic motors) were identified.
Conclusions:
- Farnesylated proteins significantly contribute to the regulation of cell cycle progression.
- FTIs represent a potential therapeutic strategy by disrupting cell cycle control in cancer.